TR

Tri Ri Asset Management Corp

13F
Tri Ri Asset Management Corp
Last update 2024-11-26 29 Stocks (0 new)
Value $197.00 Mil Turnover 0 %
Countries:
Tri Ri Asset Management Corp Top Holdings of 2024-09-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
PLTR
Palantir Technologies Inc
629,124
23,403.4
0%
11.860
0%
0.030
+63.70%
+102.99%
362,293.8
Software
NVO
Novo Nordisk AS
145,095
17,276.5
0%
8.750
0%
0.000
+10.73%
-24.03%
285,753.8
Drug Manufacturers
META
Meta Platforms Inc
24,407
13,971.5
0%
7.080
0%
0.000
+40.55%
+20.48%
1,770,790.4
Interactive Media
CMG
Chipotle Mexican Grill Inc
234,200
13,494.6
0%
6.840
0%
0.020
+11.96%
-10.56%
72,663.3
Restaurants
TSLA
Tesla Inc
42,080
11,145.3
0%
5.650
0%
0.000
+36.57%
-18.37%
1,061,788.2
Vehicles & Parts
AMZN
Amazon.com Inc
52,706
9,820.7
0%
4.980
0%
0.000
+31.01%
+3.07%
2,400,675.8
Retail - Cyclical
VRTX
Vertex Pharmaceuticals Inc
18,762
8,725.8
0%
4.420
0%
0.010
-5.99%
+14.18%
118,077.9
Biotechnology
UBER
Uber Technologies Inc
109,675
8,243.2
0%
4.180
0%
0.010
+20.40%
+50.18%
189,438.9
Software
UTHR
United Therapeutics Corp
21,448
7,685.9
0%
3.890
0%
0.050
+2.56%
-17.24%
13,171.6
Drug Manufacturers
ABNB
Airbnb Inc
50,092
6,352.2
0%
3.220
0%
0.010
+23.64%
+6.03%
86,002.4
Travel & Leisure

Tri Ri Asset Management Corp's Historical Top Holdings Breakdowns

Tri Ri Asset Management Corp Total Holding History ($B)

To

Tri Ri Asset Management Corp's Asset Allocation

To

Tri Ri Asset Management Corp Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Tri Ri Asset Management Corp's Hypothetical Growth since 2024-09-30

Tri Ri Asset Management Corp's Yearly Returns

Year Portfolio % % Excess Gain %

Tri Ri Asset Management Corp's Holdings Heat Map

Size field:

Tri Ri Asset Management Corp's Holdings Bubble Chart

Tri Ri Asset Management Corp News

  • 1

Discussions on Tri Ri Asset Management Corp

No discussions yet.